<DOC>
	<DOCNO>NCT03058835</DOCNO>
	<brief_summary>The overall aim study assess attitude toward PrEP , feasibility Truvada PrEP procurement establish access procedure , adherence Truvada PrEP among US woman risk HIV acquisition .</brief_summary>
	<brief_title>IN-US-276-1340 : Pre-Exposure Prophylaxis Prevent HIV Acquisition US Women : A Demonstration Project</brief_title>
	<detailed_description>Study Design : This 24 week prospective pilot study assess attitude toward feasibility use Truvada PrEP population woman risk HIV acquisition.At site 31 HIV- uninfected woman desire PrEP enrol site ( confirm number ) . We consent 50 woman include screen failures.The study assess attitude towards adherence PrEP questionnaires week 12 24 . Tenofovir level procure week 12 24 week PrEP use assess adherence PrEP . Primary objective : 1 . Describe attitudes toward PrEP among population woman risk HIV acquisition , live HIV prevalent area . 2 . Assess feasibility Truvada procurement establish Gilead access program 3 . Evaluate adherence week 12 week 24 use dry blood spot Secondary objective : 1 . Describe HIV incidence 2 . Describe association positive negative attitude toward PrEP acceptance PrEP subsequent adherence 3 . Assess adherence week 12 24 4 . Evaluate relationship PrEP adherence sexual activity 5 . Compare geographic area respect PrEP attitude 6 . Mentor junior investigator site .</detailed_description>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>18 64 year old Able give consent `` At risk '' HIV define follow : 1. unprotected sex ( past 6 month ) 1 men unknown HIV status 2. evaluate STI within 6 month prior screen 3. sex last 6 month HIVinfected partner 4 . IDU report use previously use share needle past 6 month methadone , buprenorphine , suboxone treatment program past 6 month engage highrisk sexual behavior 5. individual engage transactional sex ( i.e sex money , drug , housing ) 6 . Infrequently use condom sex 1 partner unknown HIV status know substantial risk HIV infection ( IDU bisexual male partner ) CrCl â‰¥ 60 ml/min HIV uninfected woman desire PrEP Active alcohol drug use dependence may interfere adherence study requirement HIVinfected screen enrollment Estimated CrCl &lt; 60 mL/min Past participation HIV vaccine study Positive Hepatitis B surface antigen test Underlying medical condition survival unlikely followup period Any condition opinion study staff would make participation study unsafe interfere achieve study objective Pregnant breast feed Actively try achieve pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Truvada</keyword>
</DOC>